PHK
AMLX icon

Point72 Hong Kong’s Amylyx Pharmaceuticals AMLX Stock Holding History

Point72 Hong Kong’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,100
Closed -$75.1K – 536
2023
Q4 		$75.1K Buy
+5,100
New +$78.2K ﹤0.01% 499
2022
Q2 		– Sell
-1,159
Closed -$15K – 1883
2022
Q1 		$15K Buy
+1,159
New +$26.2K ﹤0.01% 1560

Other funds holding AMLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Hong Kong's AMLX Position: Q1 2024 in Review

Point72 Hong Kong sold out of Amylyx Pharmaceuticals (AMLX) in Q1 2024, closing a stake of 5,100 shares — an estimated $75.1K sold.

Point72 Hong Kong first reported a position in AMLX in Q1 2022 and held it in 2 quarters. The position peaked at $75.1K in Q4 2023. 143 funds tracked by Wall St. Rank hold AMLX as of Q1 2024.

  • Point72 Hong Kong reported no remaining Amylyx Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 5,100 Amylyx Pharmaceuticals shares in Q1 2024, an estimated $75.1K.
  • Point72 Hong Kong first reported a position in Amylyx Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Point72 Hong Kong's Amylyx Pharmaceuticals position peaked at $75.1K in Q4 2023.
  • 143 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2024.

Based on Point72 Hong Kong's 13F filing for Q1 2024, filed 15 May 2024.